Document:

Exhibit 10.5

  

     

  INDEMNITY AGREEMENT

   

  THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of December 8, 2021, by and between Sculptor Acquisition Corp I, a Cayman Islands exempted company (the “Company”), and the undersigned director or officer (“Indemnitee”).

   

  WHEREAS, highly competent persons have become more reluctant to serve publicly-held companies and corporations as directors or officers or in other capacities unless they are provided with adequate protection through insurance or
      adequate indemnification against inordinate risks of claims and actions against them arising out of their service to and activities on behalf of such companies and corporations;

   

  WHEREAS, the Board of Directors of the Company (the “Board”) has determined that, in order to attract and retain qualified individuals, the Company will attempt to
      maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its subsidiaries from certain liabilities. The amended and restated memorandum and articles of association of the Company (as amended
      and/or restated from time to time) (the “Articles”) provide for the indemnification of the officers and directors of the Company. Indemnitee may also be entitled to indemnification pursuant to applicable Cayman Islands law. The Articles provide that
      the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and members of the Board, officers and other persons with respect to indemnification, hold harmless,
      exoneration, advancement and reimbursement rights;

   

  WHEREAS, the uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such persons;

   

  WHEREAS, the Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests of the Company’s shareholders and that the Company should act to assure such persons that
      there will be increased certainty of such protection in the future;

   

  WHEREAS, it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, hold harmless, exonerate and to advance expenses on behalf of, such persons to the fullest extent permitted by
      applicable law and the Articles so that they will serve or continue to serve the Company free from undue concern that they will not be so protected against liabilities;

   

  WHEREAS, this Agreement is a supplement to and in furtherance of the Articles of the Company and any resolutions adopted pursuant thereto, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of
      Indemnitee thereunder; and

   

  WHEREAS, Indemnitee may not be willing to serve as a director or officer of or in another capacity for the Company without adequate protection, and the Company desires Indemnitee to serve in such capacity. Indemnitee is willing to
      serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that he or she be so indemnified.

  

     

  
    1

    
      

  

  NOW, THEREFORE, in consideration of the premises and the covenants contained herein and subject to the provisions of the letter agreement dated as of December 8, 2021 among the Company, Indemnitee and the other parties thereto, the
      Company and Indemnitee do hereby covenant and agree as follows:

   

  	1.	
          SERVICES TO THE COMPANY

        

   

  In consideration of the Company’s covenants and obligations hereunder, Indemnitee will serve or continue to serve as a director or officer of or in another capacity for the Company, as
    applicable, for so long as Indemnitee is duly elected, appointed or retained or until Indemnitee tenders his or her resignation or until Indemnitee is removed. The foregoing notwithstanding, this Agreement shall continue in full force and effect after
    Indemnitee has ceased to serve as a director or officer of or in any other capacity for the Company, as provided in Section 17. This Agreement, however, shall not impose any obligation on Indemnitee or the Company to continue Indemnitee’s service to
    the Company beyond any period otherwise required by applicable law and the Articles or by other agreements or commitments of the parties, if any.

   

  	2.	
          DEFINITIONS

        

   

  As used in this Agreement:

   

  	

           	(a)	
          References to “agent” shall mean any person who is or was a director or officer of, or who serves or served in any other capacity for, the Company or a
            subsidiary of the Company or other person authorized by the Company to act for the Company, to include such person serving in such capacity as a director or officer of or in any other capacity for another company, corporation, partnership,
            limited liability company, joint venture, trust or other enterprise at the request of, for the convenience of, or to represent the interests of the Company or a subsidiary of the Company.

        

   

  	

           	(b)	
          The terms “Beneficial Owner” and “Beneficial Ownership” shall have the meanings set forth in
            Rule 13d-3 promulgated under the Exchange Act as in effect on the date hereof.

        

   

  	

           	(c)	
          A “Change in Control” shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the following events:

        

   

  	

           	(i)	
          Acquisition of Shares by Third Party. Other than Sculptor Acquisition Sponsor I, a limited liability company registered in the Cayman Islands (the “Sponsor”) or any of its affiliates, any Person is or becomes
              the Beneficial Owner, directly or indirectly, of securities of the Company representing fifteen percent (15%) or more of the combined voting power of the Company’s then outstanding securities entitled to vote generally in the appointment of
              directors, unless (1) the change in the relative Beneficial Ownership of the Company’s securities by any Person results solely from a reduction in the aggregate number of outstanding shares of securities entitled to vote generally in the
              appointment of directors, or (2) such acquisition was approved in advance by the Continuing Directors and such acquisition would not constitute a Change in Control under part (iii) of this definition;

        

  

     

  
    2

    
      

  

  	

           	(ii)	
          Change in Board of Directors.
              Individuals who, as of the date hereof, constitute the Board, and any new director whose appointment by the Board or nomination for appointment by the Company’s shareholders was approved by a vote of at least two thirds of the directors then
              still in office who were directors on the date hereof or whose appointment on or nomination for appointment was previously so approved (collectively, the “Continuing Directors”),
              cease for any reason to constitute at least a majority of the members of the Board;

        

   

  	

           	(iii)	
          Corporate Transactions. The
              effective date of a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination, involving the Company and one or more businesses or entities (a “Business Combination”), in each case, unless, following such Business Combination: (1) all or substantially all of the individuals and entities who were the Beneficial Owners of securities entitled to vote generally in the
              appointment of directors immediately prior to such Business Combination beneficially own, directly or indirectly, more than 51% of the combined voting power of the then outstanding securities of the Company entitled to vote generally in the
              appointment of directors resulting from such Business Combination (including, without limitation, a company or corporation which as a result of such transaction owns the Company or all or substantially all of the Company’s assets either
              directly or through one or more Subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination, of the securities entitled to vote generally in the appointment of directors; (2) other
              than an affiliate of the Sponsor, no Person (excluding any company or corporation resulting from such Business Combination) is the Beneficial Owner, directly or indirectly, of 15% or more of the combined voting power of the then outstanding
              securities entitled to vote generally in the appointment of directors of the surviving company or corporation except to the extent that such ownership existed prior to the Business Combination; and (3) at least a majority of the board of
              directors of the company or corporation resulting from such Business Combination were Continuing Directors at the time of the execution of the initial agreement, or of the action of the Board, providing for such Business Combination;

        

   

  	

           	(iv)	
          Liquidation. The approval by
              the shareholders of the Company of a complete liquidation of the Company or an agreement or series of agreements for the sale or disposition by the Company of all or substantially all of the Company’s assets, other than factoring the
              Company’s current receivables or escrows due (or, if such approval is not required, the decision by the Board to proceed with such a liquidation, sale, or disposition in one transaction or a series of related transactions); or

        

  

     

  
    3

    
      

  

  	

           	(v)	
          Other Events. There occurs any
              other event of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A of Regulation 14A (or a response to any similar item on any similar schedule or form) promulgated under the Exchange Act, whether or not
              the Company is then subject to such reporting requirement.

        

   

  	

           	(d)	
          “Corporate Status” describes the status of a person who is or was a director or officer of, or who serves or served in any other capacity for, the Company
            or any other Enterprise which such person is or was serving at the request of the Company.

        

   

  	

           	(e)	
          “Delaware Court” shall mean the Court of Chancery of the State of Delaware.

        

   

  	

           	(f)	
          “Disinterested Director” shall mean a director of the Company who is not and was not a party to the Proceeding in respect of which
            indemnification is sought by Indemnitee.

        

   

  	

           	(g)	
          “Enterprise” shall mean the Company and any other company or corporation, constituent company or corporation (including any constituent of a constituent) absorbed in a consolidation or merger to
                which the Company (or any of its wholly owned subsidiaries) is a party, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at the request of the
                Company as a director or officer or in any other capacity.

        

   

  	

           	(h)	
          “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.

        

   

  	

           	(i)	
          “Expenses” shall include all direct and indirect costs, fees and expenses of any type or nature whatsoever, including, without limitation, all reasonable
            attorneys’ fees and costs, retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, fees of private investigators and professional advisors, duplicating costs, printing and binding costs, telephone charges,
            postage, delivery service fees, fax transmission charges, secretarial services and all other disbursements, obligations or expenses in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing
            to be a witness in, settlement or appeal of, or otherwise participating in, a Proceeding, including reasonable compensation for time spent by the Indemnitee for which he or she is not otherwise compensated by the Company or any third party.
            Expenses also shall include Expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation the principal, premium, security for, and other costs relating to any cost bond, supersedeas bond, or other
            appeal bond or its equivalent. Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee.

        

   

  	

           	(j)	
          References to “fines” shall include any excise tax assessed on Indemnitee with respect to any employee benefit plan.

        

  

     

  
    4

    
      

  

  	

           	(k)	
          References to “serving at the request of the Company” shall include any service as a director or officer of or in any other capacity for the Company which
            imposes duties on, or involves services by, such director, officer or person with respect to an employee benefit plan, its participants or beneficiaries; and if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be
            in the best interests of the participants and beneficiaries of an employee benefit plan, Indemnitee shall be deemed to have acted in a manner “not opposed to the best interests of the Company”
            as referred to in this Agreement.

        

   

  	

           	(l)	
          “Independent Counsel” shall mean a law firm or a member of a law firm with significant experience in matters of corporate law and that neither presently is,
            nor in the past five years has been, retained to represent: (i) the Company or Indemnitee in any matter material to either such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees under
            similar indemnification agreements); or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent
              Counsel” shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine
            Indemnitee’s rights under this Agreement.

        

   

  	

           	(m)	
          The term “Person” shall have the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act as in effect on the date hereof; provided, however,
            that “Person” shall exclude: (i) the Company; (ii) any Subsidiaries of the Company; (iii) any employment benefit plan of the Company or of a Subsidiary of the Company or of any company
            or corporation owned, directly or indirectly, by the shareholders of the Company in substantially the same proportions as their ownership of shares of the Company; and (iv) any trustee or other fiduciary holding securities under an employee
            benefit plan of the Company or of a Subsidiary of the Company or of a company or corporation owned directly or indirectly by the shareholders of the Company in substantially the same proportions as their ownership of shares of the Company.

        

   

  	

           	(n)	
          The term “Proceeding” shall include any threatened, pending or completed action, suit, arbitration, mediation, alternate dispute resolution mechanism,
            investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought in the right of the Company or otherwise and whether of a civil (including intentional or unintentional tort claims),
            criminal, administrative or investigative or related nature, in which Indemnitee was, is, will or might be involved as a party or otherwise by reason of the fact that Indemnitee is or was a director or officer of, or serves or served in any
            other capacity for, the Company, by reason of any action (or failure to act) taken by him or her or of any action (or failure to act) on his or her part while acting as a director or officer of, or in any other capacity for, the Company, or by
            reason of the fact that he or she is or was serving at the request of the Company as a director or officer of or in any other capacity for any other Enterprise, in each case whether or not serving in such capacity at the time any liability or
            expense is incurred for which indemnification, reimbursement, or advancement of expenses can be provided under this Agreement.

        

  

     

  
    5

    
      

  

  	

           	(o)	
          The term “Subsidiary,” with respect to any Person, shall mean any company, corporation, limited liability company, partnership, joint venture, trust or
            other entity of which a majority of the voting power of the voting equity securities or equity interest is owned, directly or indirectly, by that Person.

        

   

  	

           	(p)	
          The phrase “to the fullest extent permitted by applicable law and the Articles” shall include, but not be limited to: (a) to the fullest extent authorized or permitted by the provision of applicable Cayman Islands
            law that authorizes or contemplates additional indemnification by agreement, or the corresponding provision of any amendment to or replacement of applicable Cayman Islands law, and (b) to the fullest extent authorized or permitted by any
            amendments to or replacements of applicable Cayman Islands law adopted after the date of this Agreement that increase the extent to which a company or corporation may indemnify its officers or directors or those who serve it in any other
            capacity.

        

   

  	3.	
          INDEMNITY IN THIRD-PARTY PROCEEDINGS

        

   

  To the fullest extent permitted by applicable law and the Articles, the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the provisions of this
    Section 3 if Indemnitee was, is, or is threatened to be made, a party to or a participant (as a witness, deponent or otherwise) in any Proceeding, other than a Proceeding by or in the right of the Company to procure a judgment in its favor by reason of
    Indemnitee’s Corporate Status. Pursuant to this Section 3, Indemnitee shall be indemnified, held harmless and exonerated against all Expenses, judgments, liabilities, fines, penalties and amounts paid in settlement (including all interest, assessments
    and other charges paid or payable in connection with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement) actually, and reasonably incurred by Indemnitee or on his or her behalf in connection with such Proceeding
    or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the Company and, in the case of a criminal Proceeding, had no reasonable cause to
    believe that his or her conduct was unlawful; provided, in no event shall Indemnitee be entitled to be indemnified, held harmless or advanced any amounts hereunder in respect of any Expenses, judgments, liabilities, fines, penalties and amounts paid in
    settlement (if any) that Indemnitee may incur by reason of his or her own actual fraud, willful default or willful neglect. Indemnitee shall not be found to have committed actual fraud, willful default or willful neglect for any purpose of this
    Agreement unless or until a court of competent jurisdiction shall have made a finding to that effect.

   

  	4.	
          INDEMNITY IN PROCEEDINGS BY OR IN THE RIGHT OF THE COMPANY

        

   

  To the fullest extent permitted by applicable law and the Articles, the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the provisions of this
    Section 4 if Indemnitee was, is, or is threatened to be made, a party to or a participant (as a witness, deponent or otherwise) in any Proceeding by or in the right of the Company to procure a judgment in its favor by reason of Indemnitee’s Corporate
    Status. Pursuant to this Section 4, Indemnitee shall be indemnified, held harmless and exonerated against all Expenses actually and reasonably incurred by him or her or on his or her behalf in connection with such Proceeding or any claim, issue or
    matter therein, if Indemnitee acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the Company. No indemnification, hold harmless or exoneration for Expenses shall be made under this Section
    4 in respect of any claim, issue or matter as to which Indemnitee shall have been finally adjudged by a court of competent jurisdiction to be liable to the Company, unless and only to the extent that any court in which the Proceeding was brought or the
    Delaware Court shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification, to be held harmless or to exoneration.

  

     

  
    6

    
      

  

  	5.	
          INDEMNIFICATION FOR EXPENSES OF A PARTY WHO IS WHOLLY OR PARTLY SUCCESSFUL

        

   

  Notwithstanding any other provisions of this Agreement, but subject to Section 27, to the extent that Indemnitee was or is, by reason of Indemnitee’s Corporate Status, a party to (or a
    participant in) and is successful, on the merits or otherwise, in any Proceeding or in defense of any claim, issue or matter therein, in whole or in part, the Company shall, to the fullest extent permitted by applicable law and the Articles, indemnify,
    hold harmless and exonerate Indemnitee against all Expenses actually and reasonably incurred by him or her in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or
    more but less than all claims, issues or matters in such Proceeding, the Company shall, to the fullest extent permitted by applicable law and the Articles, indemnify, hold harmless and exonerate Indemnitee against all Expenses actually and reasonably
    incurred by him or her or on his or her behalf in connection with each successfully resolved claim, issue or matter. If Indemnitee is not wholly successful in such Proceeding, the Company also shall, to the fullest extent permitted by applicable law
    and the Articles, indemnify, hold harmless and exonerate Indemnitee against all Expenses reasonably incurred in connection with a claim, issue or matter related to any claim, issue, or matter on which Indemnitee was successful. For purposes of this
    Section 5 and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.

   

  	6.	
          INDEMNIFICATION FOR EXPENSES OF A WITNESS

        

   

  Notwithstanding any other provision of this Agreement, but subject to Section 27, to the extent that Indemnitee is, by reason of his or her Corporate Status, a witness or deponent in
    any Proceeding to which Indemnitee is not a party or threatened to be made a party, he or she shall, to the fullest extent permitted by applicable law and the Articles, be indemnified, held harmless and exonerated against all Expenses actually and
    reasonably incurred by him or her or on his or her behalf in connection therewith.

   

  	7.	
          ADDITIONAL INDEMNIFICATION, HOLD HARMLESS AND EXONERATION RIGHTS

        

   

  Notwithstanding any limitation in Sections 3, 4 or 5, but subject to Section 27, the Company shall, to the fullest extent permitted by applicable law and the Articles, indemnify, hold
    harmless and exonerate Indemnitee if Indemnitee is a party to or threatened to be made a party to any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) against all Expenses, judgments, fines,
    penalties and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement) actually and reasonably
    incurred by Indemnitee in connection with the Proceeding. No indemnification, hold harmless or exoneration rights shall be available under this Section 7 on account of Indemnitee’s conduct which constitutes a breach of Indemnitee’s duty of loyalty to
    the Company or its shareholders or is an act or omission not in good faith or which involves intentional misconduct, actual fraud, willful default or willful neglect or a knowing violation of the law.

  

     

  
    7

    
      

  

  	8.	
          CONTRIBUTION IN THE EVENT OF JOINT LIABILITY

        

   

  	

           	(a)	
          To the fullest extent permissible under applicable law and the Articles, if the indemnification, hold harmless and/or exoneration rights provided for in this Agreement are unavailable to Indemnitee in whole or in
            part for any reason whatsoever, the Company, in lieu of indemnifying, holding harmless or exonerating Indemnitee, shall pay, in the first instance, the entire amount incurred by Indemnitee, whether for judgments, liabilities, fines, penalties,
            amounts paid or to be paid in settlement and/or for Expenses, in connection with any Proceeding without requiring Indemnitee to contribute to such payment, and the Company hereby waives and relinquishes any right of contribution it may have at
            any time against Indemnitee.

        

   

  	

           	(b)	
          The Company shall not enter into any settlement of any Proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such Proceeding) unless such settlement provides for a full and final
            release of all claims asserted against Indemnitee.

        

   

  	

           	(c)	
          The Company hereby agrees to fully indemnify, hold harmless and exonerate Indemnitee from any claims for contribution which may be brought by directors or officers of, or by those who serve in any other capacity for,
            the Company other than Indemnitee who may be jointly liable with Indemnitee. Indemnitee shall seek payments or advances from the Company only to the extent that such payments or advances are unavailable from any insurance policy of the Company
            covering Indemnitee.

        

   

  	9.	
          EXCLUSIONS

        

   

  Notwithstanding any provision in this Agreement, but subject to Section 27, the Company shall not be obligated under this Agreement to make any indemnification, advance Expenses, hold
    harmless or exoneration payment in connection with any claim made against Indemnitee:

   

  	

           	(a)	
          for which payment has actually been received by or on behalf of Indemnitee under any insurance policy or other indemnity or advancement provision and which payment has not subsequently been returned, except with
            respect to any excess beyond the amount actually received under any insurance policy, contract, agreement, other indemnity or advancement provision or otherwise;

        

   

  	

           	(b)	
          for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning of Section 16(b) of the Exchange Act (or any successor rule) or
            similar provisions of state statutory law or common law; or

        

   

  
    8

    
      

  

  	

           	(c)	
          except as otherwise provided in Sections 14(f) and (g) hereof, prior to a Change in Control, in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any
            part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers or other indemnitees, unless (i) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation or (ii) the Company
            provides the indemnification, hold harmless or exoneration payment, in its sole discretion, pursuant to the powers vested in the Company under applicable law and the Articles.

        

   

  	10.	
          ADVANCES OF EXPENSES; DEFENSE OF CLAIM

        

   

  	

           	(a)	
          Notwithstanding any provision of this Agreement to the contrary, but subject to Section 27, and to the fullest extent not prohibited by applicable law and the Articles, the Company shall pay the Expenses incurred by
            Indemnitee (or reasonably expected by Indemnitee to be incurred by Indemnitee within three months) in connection with any Proceeding within ten (10) days after the receipt by the Company of a statement or statements requesting such advances
            from time to time, prior to the final disposition of any Proceeding. Advances shall, to the fullest extent permitted by applicable law and the Articles, be unsecured and interest free. Advances shall, to the fullest extent permitted by
            applicable law and the Articles, be made without regard to Indemnitee’s ability to repay the Expenses and without regard to Indemnitee’s ultimate entitlement to be indemnified, held harmless or exonerated under the other provisions of this
            Agreement. Advances shall include any and all reasonable Expenses incurred pursuing a Proceeding to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company to support the advances
            claimed. To the fullest extent required by applicable law and the Articles, such payments of Expenses in advance of the final disposition of the Proceeding shall be made only upon the Company’s receipt of an undertaking, by or on behalf of
            Indemnitee, to repay the advanced amounts to the extent that it is ultimately determined that Indemnitee is not entitled to be indemnified, held harmless or exonerated by the Company under the provisions of this Agreement, applicable law and
            the Articles or otherwise. If it shall be determined by a final judgment or other final adjudication that Indemnitee was not so entitled to indemnification or to be held harmless or exonerated, any advancement shall be returned to the Company
            (without interest) by the Indemnitee. This Section 10(a) shall not apply to any claim made by Indemnitee for which an indemnification, hold harmless or exoneration payment is excluded pursuant to Section 9, but shall apply to any Proceeding
            referenced in Section 9(b) prior to a final determination that Indemnitee is liable therefor.

        

   

  	

           	(b)	
          The Company will be entitled to participate in the Proceeding at its own expense.

        

   

  
    9

    
      

  

  	

           	(c)	
          The Company shall not settle any action, claim or Proceeding (in whole or in part) which would impose any Expense, judgment, fine, penalty or limitation on Indemnitee without Indemnitee’s prior
            written consent.

        

   

  	11.	
          PROCEDURE FOR NOTIFICATION AND APPLICATION FOR INDEMNIFICATION

        

   

  	

           	(a)	
          Indemnitee agrees to notify promptly the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding, claim, issue or
            matter therein which may be subject to indemnification, hold harmless or exoneration rights, or advancement of Expenses covered hereunder. The failure of Indemnitee to so notify the Company shall not relieve the Company of any obligation which
            it may have to Indemnitee under this Agreement, or otherwise.

        

   

  	

           	(b)	
          Indemnitee may deliver to the Company a written application to indemnify, hold harmless or exonerate Indemnitee in accordance with this Agreement. Such application(s) may be delivered from time to time and at such
            time(s) as Indemnitee deems appropriate in his or her sole discretion. Following such a written application for indemnification by Indemnitee, Indemnitee’s entitlement to indemnification shall be determined according to Section 12(a) of this
            Agreement.

        

   

  	12.	
          PROCEDURE UPON APPLICATION FOR INDEMNIFICATION

        

   

  	

           	(a)	
          A determination, if required by applicable law and the Articles, with respect to Indemnitee’s entitlement to indemnification shall be made in the specific case by one of the following methods, which shall be at the
            election of Indemnitee: (i) by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (ii) by a committee of such directors designated by majority vote of such directors, (iii) if there are no Disinterested
            Directors or if such directors so direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee, or (iv) by vote of the shareholders by ordinary resolution. The Company promptly will advise
            Indemnitee in writing with respect to any determination that Indemnitee is or is not entitled to indemnification, including a description of any reason or basis for which indemnification has been denied. If it is so determined that Indemnitee
            is entitled to indemnification, payment to Indemnitee shall be made within ten (10) days after such determination. Indemnitee shall reasonably cooperate with the person, persons or entity making such determination with respect to Indemnitee’s
            entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably
            available to Indemnitee and reasonably necessary to such determination. Any costs or Expenses (including reasonable attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating with the person, persons or entity making such
            determination shall be borne by the Company (irrespective of the determination as to Indemnitee’s entitlement to indemnification) and the Company hereby agrees to indemnify and to hold Indemnitee harmless therefrom.

        

   

  
    10

    
      

  

  	

           	(b)	
          In the event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 12(a) hereof, the Independent Counsel shall be selected as provided in this Section 12(b). The
            Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection be made by the Board), and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so
            selected and certifying that the Independent Counsel so selected meets the requirements of “Independent Counsel” as defined in Section 2 of this Agreement. If the Independent Counsel is selected by the Board, the Company shall give written
            notice to Indemnitee advising him or her of the identity of the Independent Counsel so selected and certifying that the Independent Counsel so selected meets the requirements of “Independent Counsel” as defined in Section 2 of this Agreement.
            In either event, Indemnitee or the Company, as the case may be, may, within ten (10) days after such written notice of selection shall have been received, deliver to the Company or to Indemnitee, as the case may be, a written objection to such
            selection; provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as defined in Section 2 of this Agreement, and the objection
            shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If such written objection is so made and substantiated, the Independent
            Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court of competent jurisdiction has determined that such objection is without merit. If, within twenty (20) days after submission by
            Indemnitee of a written request for indemnification pursuant to Section 11(b) hereof, no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition the Delaware Court for resolution of any
            objection which shall have been made by the Company or Indemnitee to the other’s selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the Delaware Court, and the person with respect to whom
            all objections are so resolved or the person so appointed shall act as Independent Counsel under Section 12(a) hereof. Upon the due commencement of any judicial proceeding or arbitration pursuant to Section 14(a) of this Agreement, Independent
            Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing).

        

   

  	

           	(c)	
          The Company agrees to pay the reasonable fees and expenses of Independent Counsel and to fully indemnify and hold harmless such Independent Counsel against any and all Expenses, claims, liabilities and damages
            arising out of or relating to this Agreement or its engagement pursuant hereto.

        

   

  
    11

    
      

  

  	13.	
          PRESUMPTIONS AND EFFECT OF CERTAIN PROCEEDINGS

        

   

  	

           	(a)	
          In making a determination with respect to entitlement to indemnification hereunder, the person, persons or entity making such determination shall presume that Indemnitee is entitled to indemnification under this
            Agreement if Indemnitee has submitted a request for indemnification in accordance with Section 11(b) of this Agreement, and the Company shall have the burden of proof to overcome that presumption in connection with the making by any person,
            persons or entity of any determination contrary to that presumption. Neither the failure of the Company (including by the Disinterested Directors or Independent Counsel) to have made a determination prior to the commencement of any action
            pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company (including by the Disinterested Directors or Independent
            Counsel) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.

        

   

  	

           	(b)	
          If the person, persons or entity empowered or selected under Section 12 of this Agreement to determine whether Indemnitee is entitled to indemnification shall not have made a determination within thirty (30) days
            after receipt by the Company of the request therefor, the requisite determination of entitlement to indemnification shall, to the fullest extent permitted by applicable law and the Articles, be deemed to have been made and Indemnitee shall be
            entitled to such indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for
            indemnification, or (ii) a final judicial determination that any or all such indemnification is expressly prohibited under applicable law and the Articles; provided, however, that such 30-day period may be extended for a reasonable time, not to
            exceed an additional fifteen (15) days, if the person, persons or entity making the determination with respect to entitlement to indemnification in good faith requires such additional time for the obtaining or evaluating of documentation and/or
            information relating thereto.

        

   

  	

           	(c)	
          The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly
            provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which he or she reasonably believed to be in or not opposed to
            the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his or her conduct was unlawful.

        

    

     

  
    12

    
      

  

  	

           	(d)	
          For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee’s action is based on the records or books of account of the Enterprise, including financial
            statements, or on information supplied to Indemnitee by the directors or officers of, or by those who serve in any other capacity for, the Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise, its
            Board, any committee of the Board or any director or officer of, or any person who serves in any capacity for, the Enterprise, or on information or records given or reports made to the Enterprise, its Board, any committee of the Board or any
            director or officer of, or any person who serves in any capacity for, the Enterprise by an independent certified public accountant or by an appraiser or other expert selected by the Enterprise, its Board, any committee of the Board or any
            director or officer of, or person who serves in any capacity for, the Enterprise. The provisions of this Section 13(d) shall not be deemed to be exclusive or to limit in any way the other circumstances in which Indemnitee may be deemed or found
            to have met the applicable standard of conduct set forth in this Agreement.

        

   

  	

           	(e)	
          The knowledge and/or actions, or failure to act, of any other director or officer of or any other person who serves in any capacity for the Enterprise shall not be imputed to Indemnitee for purposes of determining
            the right to indemnification under this Agreement.

        

   

  	14.	
          REMEDIES OF INDEMNITEE

        

   

  	

           	(a)	
          In the event that (i) a determination is made pursuant to Section 12 of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses, to the fullest extent
            permitted by applicable law and the Articles, is not timely made pursuant to Section 10 of this Agreement, (iii) no determination of entitlement to indemnification shall have been made pursuant to Section 12(a) of this Agreement within thirty
            (30) days after receipt by the Company of the request for indemnification, (iv) payment of indemnification is not made pursuant to Sections 5, 6, 7 or the last sentence of Section 12(a) of this Agreement within ten (10) days after receipt by
            the Company of a written request therefor, (v) a contribution payment is not made in a timely manner pursuant to Section 8 of this Agreement, (vi) payment of indemnification pursuant to Section 3 or 4 of this Agreement is not made within ten
            (10) days after a determination has been made that Indemnitee is entitled to indemnification, or (vii) payment to Indemnitee pursuant to any hold harmless or exoneration rights under this Agreement or otherwise is not made in accordance with
            this Agreement within ten (10) days after receipt by the Company of a written request therefor, Indemnitee shall be entitled to an adjudication by the Delaware Court to such indemnification, hold harmless, exoneration, contribution or
            advancement rights. Alternatively, Indemnitee, at his or her option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules and Mediation Procedures of the American Arbitration
            Association. Except as set forth herein, the Commercial Arbitration Rules and Mediation Procedures of the American Arbitration Association shall apply to any such arbitration. The Company shall not oppose Indemnitee’s right to seek any such
            adjudication or award in arbitration.

        

   

  	

           	(b)	
          In the event that a determination shall have been made pursuant to Section 12(a) of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this
            Section 14 shall be conducted in all respects as a de novo trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination.

        

    

     

  
    13

    
      

  

  	

           	(c)	
          In any judicial proceeding or arbitration commenced pursuant to this Section 14, Indemnitee shall be presumed to be entitled to be indemnified, held harmless, exonerated to receive advancement of Expenses under this
            Agreement and the Company shall have the burden of proving Indemnitee is not entitled to be indemnified, held harmless, exonerated and to receive advancement of Expenses, as the case may be, and the Company may not refer to or introduce into
            evidence any determination pursuant to Section 12(a) of this Agreement adverse to Indemnitee for any purpose. If Indemnitee commences a judicial proceeding or arbitration pursuant to this Section 14, Indemnitee shall not be required to
            reimburse the Company for any advances pursuant to Section 10 until a final determination is made with respect to Indemnitee’s entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed).

        

   

  	

           	(d)	
          If a determination shall have been made pursuant to Section 12(a) of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or
            arbitration commenced pursuant to this Section 14, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request
            for indemnification, or (ii) a prohibition of such indemnification under applicable law and the Articles.

        

   

  	

           	(e)	
          The Company shall be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 14 that the procedures and presumptions of this Agreement are not valid, binding and
            enforceable and shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement.

        

   

  	

           	(f)	
          The Company shall indemnify and hold harmless Indemnitee to the fullest extent permitted by applicable law and the Articles against all Expenses and, if requested by Indemnitee, shall (within ten (10) days after the
            Company’s receipt of such written request) pay to Indemnitee, to the fullest extent permitted by applicable law and the Articles, such Expenses which are incurred by Indemnitee in connection with any judicial proceeding or arbitration brought
            by Indemnitee: (i) to enforce his or her rights under, or to recover damages for breach of, this Agreement or any other indemnification, hold harmless, exoneration, advancement or contribution agreement or provision of the Articles now or
            hereafter in effect; or (ii) for recovery or advances under any insurance policy maintained by any person for the benefit of Indemnitee, regardless of the outcome and whether Indemnitee ultimately is determined to be entitled to such
            indemnification, hold harmless or exoneration right, advancement, contribution or insurance recovery, as the case may be (unless such judicial proceeding or arbitration was not brought by Indemnitee in good faith).

        

    

     

  
    14

    
      

  

  	

           	(g)	
          Interest shall be paid by the Company to Indemnitee at the legal rate under Delaware law for amounts which the Company indemnifies, holds harmless or exonerates, or advances, or is obliged to indemnify, hold harmless
            or exonerate or advance for the period commencing with the date on which Indemnitee requests indemnification, to be held harmless, exonerated, contribution, reimbursement or advancement of any Expenses and ending with the date on which such
            payment is made to Indemnitee by the Company.

        

   

  	15.	
          SECURITY

        

   

  Notwithstanding anything herein to the contrary, but subject to Section 27, to the extent requested by Indemnitee and approved by the Board, the Company may at any time and from time
    to time provide security to Indemnitee for the Company’s obligations hereunder through an irrevocable bank line of credit, funded trust or other collateral. Any such security, once provided to Indemnitee, may not be revoked or released without the
    prior written consent of Indemnitee.

   

  	16.	
          NON-EXCLUSIVITY; SURVIVAL OF RIGHTS; INSURANCE; SUBROGATION; PRIORITY OF OBLIGATIONS

        

   

  	

           	(a)	
          The rights of Indemnitee as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law and the Articles, any agreement, a vote of
            shareholders or a resolution of directors, or otherwise. No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any Proceeding
            (regardless of when such Proceeding is first threatened, commenced or completed) or claim, issue or matter therein arising out of, or related to, any action taken or omitted by such Indemnitee in his or her Corporate Status prior to such
            amendment, alteration or repeal. To the extent that a change in applicable law and the Articles, whether by statute or judicial decision, permits greater indemnification, hold harmless or exoneration rights or advancement of Expenses than would
            be afforded currently under the Articles or this Agreement, then this Agreement (without any further action by the parties hereto) shall automatically be deemed to be amended to require that the Company indemnify the Indemnitee to the fullest
            extent permitted by applicable law and the Articles. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and
            remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or
            remedy.

        

   

  
    15

    
      

  

  	

           	(b)	
          The Articles permit the Company to purchase and maintain insurance or furnish similar protection or make other arrangements including, but not limited to, providing a trust fund, letter of credit, or surety bond (“Indemnification Arrangements”) on behalf of Indemnitee against any liability asserted against him or her or incurred by or on behalf of him or her or in such capacity as a director,
            officer or agent of the Company, or arising out of his or her status as such, whether or not the Company would have the power to indemnify him or her against such liability under the provisions of this Agreement and the Articles. The purchase,
            establishment, and maintenance of any such Indemnification Arrangement shall not in any way limit or affect the rights and obligations of the Company or of Indemnitee under this Agreement except as expressly provided herein, and the execution
            and delivery of this Agreement by the Company and Indemnitee shall not in any way limit or affect the rights and obligations of the Company or the other party or parties thereto under any such Indemnification Arrangement.

        

   

  	

           	(c)	
          To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors or officers of, or those who serve in any other capacity for, any other Enterprise which such
            person serves at the request of the Company, Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director or officer or person serving in any
            other capacity under such policy or policies. If, at the time the Company receives notice from any source of a Proceeding as to which Indemnitee is a party or a participant (as a witness, deponent or otherwise), the Company has director and
            officer liability insurance in effect, the Company shall give prompt notice of such Proceeding to the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter use commercially reasonable
            efforts to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policies.

        

   

  	

           	(d)	
          In the event of any payment under this Agreement, the Company, to the fullest extent permitted by applicable law and the Articles, shall be subrogated to the extent of such payment to all of the rights of recovery of
            Indemnitee, who shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights. No such payment by the
            Company shall be deemed to relieve any insurer of its obligations.

        

   

  	

           	(e)	
          The Company’s obligation to indemnify, hold harmless, exonerate or advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company as a director or officer of or in any other capacity for
            any other Enterprise shall be reduced by any amount Indemnitee has actually received as indemnification, hold harmless or exoneration payments or advancement of expenses from such Enterprise. Notwithstanding any other provision of this
            Agreement to the contrary, but subject to Section 27, (i) Indemnitee shall have no obligation to reduce, offset, allocate, pursue or apportion any indemnification, hold harmless, exoneration, advancement, contribution or insurance coverage
            among multiple parties possessing such duties to Indemnitee prior to the Company’s satisfaction and performance of all its obligations under this Agreement, and (ii) the Company shall perform fully its obligations under this Agreement without
            regard to whether Indemnitee holds, may pursue or has pursued any indemnification, advancement, hold harmless, exoneration, contribution or insurance coverage rights against any person or entity other than the Company.

        

   

  
    16

    
      

  

  	

           	(f)	
          Notwithstanding anything contained herein, the Company is the primary indemnitor, and any indemnification or advancement obligation of the Sponsor or its affiliates or members or any other Person is secondary.

        

   

  	17.	
          DURATION OF AGREEMENT

        

   

  All agreements and obligations of the Company contained herein shall continue during the period Indemnitee serves as a director or officer of or in any other capacity for the Company
    or as a director or officer of or in any other capacity for any other company, corporation, partnership, joint venture, trust, employee benefit plan or other Enterprise which Indemnitee serves at the request of the Company and shall continue thereafter
    so long as Indemnitee shall be subject to any possible Proceeding (including any rights of appeal thereto and any Proceeding commenced by Indemnitee pursuant to Section 14 of this Agreement) by reason of his or her Corporate Status, whether or not he
    or she is acting in any such capacity at the time any liability or expense is incurred for which indemnification or advancement can be provided under this Agreement.

   

  	18.	
          SEVERABILITY

        

   

  If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the validity, legality and enforceability of the
    remaining provisions of this Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal
    or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by applicable law and the Articles; (b) such provision or provisions shall be deemed reformed to the extent necessary to
    conform to applicable law and the Articles and to give the maximum effect to the intent of the parties hereto; and (c) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any Section,
    paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby.

   

  	19.	
          ENFORCEMENT AND BINDING EFFECT

        

   

  	

           	(a)	
          The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce Indemnitee to serve as a director or officer of or in another
            capacity for the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director or officer of or in another capacity for the Company.

        

   

  	

           	(b)	
          Without limiting any of the rights of Indemnitee under the Articles as they may be amended from time to time, this Agreement constitutes the entire agreement between the parties hereto with respect to the subject
            matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof.

        

   

  
    17

    
      

  

  	

           	(c)	
          The indemnification, hold harmless, exoneration and advancement of expenses rights provided by or granted pursuant to this Agreement shall be binding upon and be enforceable by the parties hereto and their respective
            successors and assigns (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business and/or assets of the Company), shall continue as to an Indemnitee who has ceased to
            be a director or officer of or to serve in any other capacity for the Company or ceased to be a director or officer of or to serve in any other capacity for any other Enterprise at the Company’s request, and shall inure to the benefit of
            Indemnitee and his or her spouse, assigns, heirs, devisees, executors and administrators and other legal representatives.

        

   

  	

           	(d)	
          The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially all or a substantial part, of the business and/or assets of the
            Company, by written agreement in form and substance satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such
            succession had taken place.

        

   

  	

           	(e)	
          The Company and Indemnitee agree herein that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable and difficult to prove, and further agree that such breach may cause
            Indemnitee irreparable harm. Accordingly, the parties hereto agree that Indemnitee may, to the fullest extent permitted by applicable law and the Articles, enforce this Agreement by seeking, among other things, injunctive relief and/or specific
            performance hereof, without any necessity of showing actual damage or irreparable harm and that by seeking injunctive relief and/or specific performance, Indemnitee shall not be precluded from seeking or obtaining any other relief to which he
            or she may be entitled. The Company and Indemnitee further agree that Indemnitee shall, to the fullest extent permitted by applicable law and the Articles, be entitled to such specific performance and injunctive relief, including temporary
            restraining orders, preliminary injunctions and permanent injunctions, without the necessity of posting bonds or other undertaking in connection therewith. The Company acknowledges that in the absence of a waiver, a bond or undertaking may be
            required of Indemnitee by a court of competent jurisdiction, and the Company hereby waives any such requirement of such a bond or undertaking to the fullest extent permitted by applicable law and the Articles.

        

   

  	20.	
          MODIFICATION AND WAIVER

        

   

  No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the parties hereto. No waiver of any of the provisions of this Agreement shall
    be deemed or shall constitute a waiver of any other provisions of this Agreement nor shall any waiver constitute a continuing waiver.

   

  	21.	
          NOTICES

        

   

  All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been duly given (i) if delivered by hand and receipted for
    by the party to whom said notice or other communication shall have been directed, or (ii) if mailed by certified or registered mail with postage prepaid, on the third (3rd) business day after the date on which it is so mailed:

  

     

  
    18

    
      

  

  	

           	(a)	
          If to Indemnitee, at the address indicated on the signature page of this Agreement, or such other address as Indemnitee shall provide in writing to the Company.

        

   

  	

           	(b)	
          If to the Company, to:

        

   

  Sculptor Acquisition Corp I

  9 West 57th Street, 39th Floor

  New York, NY 10019

  Attention: Steven Orbuch

   

  With a copy, which shall not constitute notice, to:

   

  Ropes & Gray LLP

  1211 Avenue of the Americas

  New York, New York 10036

  Attention: Michael Littenberg,

   

  or to any other address as may have been furnished to Indemnitee in writing by the Company.

   

  	22.	
          APPLICABLE LAW AND CONSENT TO JURISDICTION

        

   

  This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, without regard to its
    conflict of laws rules. Except with respect to any arbitration commenced by Indemnitee pursuant to Section 14(a) of this Agreement, to the fullest extent permitted by applicable law and the Articles, the Company and Indemnitee hereby irrevocably and
    unconditionally: (a) agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Delaware Court and not in any other state or federal court in the United States of America or any court in any
    other country; (b) consent to submit to the exclusive jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement; (c) waive any objection to the laying of venue of any such action or
    proceeding in the Delaware Court; and (d) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Delaware Court has been brought in an improper or inconvenient forum, or is subject (in whole or in part) to
    a jury trial. To the fullest extent permitted by applicable law and the Articles, the parties hereby agree that the mailing of process and other papers in connection with any such action or proceeding in the manner provided by Section 21 or in such
    other manner as may be permitted by applicable law and the Articles, shall be valid and sufficient service thereof.

   

  	23.	
          IDENTICAL COUNTERPARTS

        

   

  This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same
    Agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.

   

     

  
    19

    
      

  

  	24.	
          MISCELLANEOUS

        

   

  The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof.

   

  	25.	
          PERIOD OF LIMITATIONS

        

   

  No legal action shall be brought and no cause of action shall be asserted by or in the right of the Company against Indemnitee, Indemnitee’s spouse, heirs, executors or personal or
    legal representatives after the expiration of two years from the date of accrual of such cause of action, and any claim or cause of action of the Company shall be extinguished and deemed released unless asserted by the timely filing of a legal action
    within such two-year period; provided, however, that if any shorter period of limitations is otherwise applicable to any such cause of action such shorter period shall govern.

   

  	26.	
          ADDITIONAL ACTS

        

   

  If for the validation of any of the provisions in this Agreement any act, resolution, approval or other procedure is required to the fullest extent permitted by applicable law and the
    Articles, the Company undertakes to cause such act, resolution, approval or other procedure to be affected or adopted in a manner that will enable the Company to fulfill its obligations under this Agreement.

   

  	27.	
          WAIVER OF CLAIMS TO TRUST ACCOUNT

        

   

  Notwithstanding anything contained herein to the contrary, Indemnitee hereby agrees that it does not have any right, title, interest or claim of any kind (each, a “Claim”) in or to any monies in the trust account established in connection with the Company’s initial public offering for the benefit of the Company and holders of shares issued in such offering,
    and hereby waives any Claim it may have in the future as a result of, or arising out of, any services provided to the Company and will not seek recourse against such trust account for any reason whatsoever. Accordingly, Indemnitee acknowledges and
    agrees that any indemnification provided hereto will only be able to be satisfied by the Company if (i) the Company has sufficient funds outside of the Trust Account to satisfy its obligations hereunder or (ii) the Company consummates a Business
    Combination.

   

  	28.	
          MAINTENANCE OF INSURANCE

        

   

  The Company shall use commercially reasonable efforts to obtain and maintain in effect during the entire period for which the Company is obligated to indemnify the Indemnitee under
    this Agreement, one or more policies of insurance with reputable insurance companies to provide the officers/directors of the Company with coverage for losses from wrongful acts and omissions and to ensure the Company’s performance of its
    indemnification obligations under this Agreement. The Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director or officer or person serving in any
    other capacity under such policy or policies. In all such insurance policies, the Indemnitee shall be named as an insured in such a manner as to provide the Indemnitee with the same rights and benefits as are accorded to the most favorably insured of
    the directors and officers of or persons serving in any other capacity for the Company.

   

  [SIGNATURE PAGE FOLLOWS]

   

     

  
    20

    
      

  

  IN WITNESS WHEREOF, the parties hereto have caused this Indemnity Agreement to be signed as of the day and year first above written.

   

    

   

    

  
    	 	
            SCULPTOR ACQUISITION CORP I

          
	 	 	 
	 	
            By:

          	 
	 	
            Name:

          	
            Steven Orbuch

          
	 	
            Title:

          	
            Chief Executive Officer and Director

          

  

   

    

  [Signature Page to Indemnity Agreement]

   

     

  
    
      

  

  
    	 	
            INDEMNITEE

          
	 	 
	 	
            By:

          	 
	 	
            Name:

          	 
	 	
            Title:

          	 

  

  

     

  [Signature Page to Indemnity Agreement]Exhibit 4.4

 

FORWARD PHARMA A/S

Option Agreement

 

This Option Agreement (this
 "Agreement") is made and entered into effective as of __________ ___, 20___ by and between Forward Pharma A/S, company
registration no. (CVR no.) 28865880, a public limited liability company duly incorporated and organized under the laws of the Kingdom
of Denmark (the "Company"), and ________________, an employee of the Company (the "Participant").

 

Grant
Date: __________ ___, 20___

 

Exercise
Price per Ordinary Share (the “Exercise Price”): USD ________

 

Total
Number of Ordinary Shares: __________ ___, 20___

 

Expiration
Date: __________ ___, 20___

 

1.     Grant
of Option.

 

1.1     Grant;
Type of Option. The Company has on the Grant Date granted to the Participant an option (the "Option") to subscribe
for the total number of Ordinary Shares set forth above, at the Exercise Price set forth above. The Option is being granted outside of
the Company’s 2014 Omnibus Equity Incentive Compensation Plan (the "Plan"); however, unless otherwise specifically
set forth herein, the Option will be governed in all respects as if issued under the Plan, as currently in effect and as may be amended
hereafter from time to time, as well as this Agreement.

 

1.2    Consideration;
Subject to Plan. The grant of the Option and its exercise are made subject to the terms and conditions of the Plan, which are incorporated
herein by reference. Capitalized terms used but not defined herein will have the meaning ascribed to them in the Plan. In the event of
a conflict between any term or provision contained herein and a term or provision of the Plan (excluding any explicit deviations from
the Plan provided for herein), the applicable terms and provisions of the Plan will govern and prevail to the extent permissible under
applicable law.

 

2.     Exercise
Period; Vesting

 

2.1     Vesting
Schedule. Subject to the Participant’s continuing employment with the Company, a Subsidiary or an Affiliate on the applicable
vesting date, the Option will become vested ______________________. The unvested portion of the Option will be cancelled for no compensation
upon termination of the Participant's employment or other service relationship for any reason (a Termination of Service), and the vested
portion of the Option shall be exercisable to the extent provided for in Section 9.6 of the Plan, provided however that the Committee
may prior to the expiration of this Option, in its sole discretion, by written notice to the Participant decide that the vested portion
of the Option shall remain exercisable as if a Termination of Service had not occurred (in which case the vested portion of the Option,
subject to the terms and conditions set forth in the Plan and this Agreement, would be exercisable pursuant to Section 2.3 below).

 

    

    

    

 

2.2      Expiration.
The Option will expire on the Expiration Date set forth above, or earlier as provided in this Agreement or the Plan.

 

2.3     Exercise
Period. The Participant may, subject to the terms and conditions set forth in the Plan and this Agreement, exercise the Option during
the period from __________ to __________.

 

2.4      Change
in Control. If the Company consummates a Change in Control (as defined below) prior to the date that the Option is vested and exercisable
in full and the Participant continues to be employed by or in other service relationship with the Company, a Subsidiary or an Affiliate
through the date of such Change in Control, 100% of the unvested portion of the Option shall vest and become exercisable immediately prior
to the consummation of such Change in Control. Notwithstanding anything in the Plan to the contrary, for purposes of this Agreement, “Change
in Control” means any issue or sale or other disposal of securities of the Company following which Nordic Biotech K/S, Nordic
Biotech Opportunity Fund K/S, NB FP Investment K/S, NB FP Investment II K/S and Rosetta Capital I, LP and all of their respective affiliates
and associates, including without limitation any of their limited or general partners and any investment vehicles in which any such limited
or general partners or their affiliates or associates may directly or indirectly participate (the “Controlling Shareholders”),
no longer, directly or indirectly, collectively hold more than 50% of the combined voting power of the Company’s then outstanding
securities, provided however that a liquidation of the Company, where the Controlling Shareholders following such liquidation, directly
or indirectly, collectively continue to hold more than 50% of the combined voting power of Forward Pharma Operations ApS’ then outstanding
securities, shall not constitute a Change in Control. For the avoidance of doubt, for the purposes of this Agreement Florian Schönharting
and any entity controlled directly or indirectly by him, whether through one or more entities, is an affiliate of Nordic Biotech K/S,
Nordic Biotech Opportunity Fund K/S, NB FP Investment K/S, NB FP Investment II K/S.

 

3.     Manner
of Exercise. To exercise any portion of the Option, the Participant (or in the case of exercise after the Participant’s death
or incapacity, the Participant’s executor, administrator, heir or legatee, as the case may be) must deliver to the Company a notice
of intent to exercise in the manner designated by the Committee and pay the Exercise Price and any applicable taxes. For the avoidance
of doubt, the exercise of the Option shall occur on the date the Participant meets all of the requirements of this Section 5. If
someone other than the Participant exercises the Option, then such person must submit documentation reasonably acceptable to the Company
verifying that such person has the legal right to exercise the Option.

 

    2

    

    

 

4.     Transferability.
Except with the prior written consent of the Committee in its sole discretion, the Option is not transferable in whole or part by the
Participant other than to a designated beneficiary upon the Participant’s death or by will or the laws of descent and distribution,
and is exercisable during the Participant’s lifetime only by her (or her legal guardian in the event of the Participant’s
incapacity). No assignment or transfer of the Option in whole or part, or the rights represented thereby, whether voluntary or involuntary,
by operation of law or otherwise (except to a designated beneficiary, upon death, by will or the laws of descent or distribution or with
the Committee’s prior written consent) will vest in the assignee or transferee any interest or right herein whatsoever, but immediately
upon such assignment or transfer the Option will be forfeited with no compensation due therefor and this Agreement will terminate and
have no further force or effect.

 

5.    Tax
Liability and Withholding. The Participant shall satisfy any and all requirements and obligations relating to applicable taxes. Without
limiting the generality of the foregoing, the Company, its Subsidiaries and Affiliates shall not be responsible for withholding any income
tax, social security, unemployment, disability insurance or other tax obligations that become due from the Participant in connection with
the grant or exercise of the Option, and the Participant shall indemnify the Company, its Subsidiaries and Affiliates against all expenses
relating to any obligation imposed by law on the Company, its Subsidiaries and Affiliates in respect of any such taxes.

 

6.     Notices.
Any notice required to be delivered to the Company under this Agreement shall be in writing and addressed to the Company’s Chief
Executive Officer at the Company’s principal corporate offices. Any notice required to be delivered to the Participant under this
Agreement shall be in writing and addressed to the Participant at the Participant’s address as shown in the records of the Company.
Either party may designate another address in writing (or by such other method approved by the Company) from time to time.

 

7.     Effect
of Changes in Capitalization. Notwithstanding the provisions of Section 10.1 of the Plan to the contrary, the first sentence
of Section 10.1 of the Plan shall apply to this Option in the event of a change in the Company’s capital structure by reason
of (a) the issuance of bonus shares of the Company (in Danish “fondsaktier”) to all of the Company’s shareholders
on a pro rata basis in accordance with their ownership interest, (b) dividends or (c) a capital decrease where amounts distributed
to shareholders do not equal the market value of the shares being redeemed as part of the capital decrease. The provisions of this Section 9
are intended to protect the Participant from any dilution of the financial value of her ownership interest that may occur as a result
of a change in the Company’s capital structure described in this Section 7. For the avoidance of doubt, the Committee may make
those adjustments it determines, in its discretion, are necessary to protect the Participant’s interest as described herein.

 

8.     Governing
Law and Venue. This Agreement will be construed and interpreted in accordance with the laws of the Kingdom of Denmark and any legal
suit, action or proceeding against us arising out of or based upon this Agreement shall be exclusively instituted in a Danish court.

 

    3

    

    

 

9.    Danish
Corporate Law Implementation. In the event of a conflict between any term or provision contained in this Agreement and a term or provision
of any document or part of any document executed and delivered with the purpose of implementing the terms and provisions of this Agreement
under Danish company law, the terms and provisions of this Agreement will govern and prevail.

 

10.   Successors
and Assigns. The Company may assign any of its rights under this Agreement. This Agreement will be binding upon and inure to the benefit
of the successors and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding
upon the Participant and the Participant’s beneficiaries, executors, administrators and the person(s) to whom this Agreement
may be transferred by will, the laws of descent or distribution or otherwise.

 

11.   Entire
Agreement; Survival; Amendment. The terms, conditions and restrictions set forth in the Plan and this Agreement constitute the entire
understanding between the parties hereto regarding the Option and supersede all previous written, oral, or implied understandings between
the parties hereto about the subject matter hereof. The Committee has the right to amend, alter, suspend, discontinue or cancel this Agreement,
prospectively or retroactively; provided, that, no such amendment shall adversely affect the Participant’s material rights
under this Agreement without the Participant’s consent. Section headings herein are for convenience only and have no effect
on the interpretation of this Agreement. The provisions of this Agreement that are intended to survive termination of a Participant’s
service shall survive such date (Termination of Service).

 

12.   Counterparts.
This Agreement may be executed in counterparts, each of which shall be deemed an original but all of which together will constitute one
and the same instrument.

 

13.   Consent
to Transfer of Personal Data. In administering the Plan or this Agreement, or to comply with applicable legal, regulatory, tax, or
accounting requirements, it may be necessary for the Company to transfer certain Participant data to an affiliate or to its outside service
providers or governmental agencies. By accepting the Option, the Participant consents, to the fullest extent permitted by law, to the
use and transfer, electronically or otherwise, of the Participant’s personal data to such entities for such purposes.

 

14.   Acceptance.
The Participant hereby acknowledges receipt of a copy of the Plan and this Agreement. The Participant has read and understands the terms
and provisions thereof and hereof, and accepts the Option subject to all of the terms and conditions of the Plan and this Agreement, including,
without limitation, Sections 12 (“No Right to Award, Employment or Service”) and 18 (“Recoupment”) of the Plan.
Participant agrees to accept as binding, conclusive and final all decisions or interpretations of the Board (or any person(s) to
whom the Board has delegated its authority pursuant to the Plan) upon any questions arising under the Plan or this Agreement.

 

[SIGNATURE PAGE FOLLOWS]

 

    4

    

    

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement
as of the date first above written.

 

	 	
    FORWARD PHARMA A/S

    

	 	 
	 	By:	                       
	 	 
	 	
    

    Name:

    Title:

	 	 
	 	PARTICIPANT
	 	 
	 	 

 

    5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]